INTENT TO SOLE SOURCE-PET RADIOPHARMACEUTICALS 508-26-3-2049-0029
Summary
AI-generated · Jun 11, 2026Intended sole-source award to supply Nuclear Medicine in the Atlanta VA Healthcare System with five specific PET radiopharmaceuticals: Amyvid (F-18 florbetapir), Tauvid (F-18 flortaucipir), Cerianna (F-18 fluoroestradiol), Posluma (F-18 flotufolastat), and Axumin (F-18 fluciclovine). The contract runs for one year with four optional years, and the vendor must provide all labor, supervision, and transportation to ensure daily delivery to the Nuclear Medicine department at the ATL VAMC.
Deliveries must be made daily to the Nuclear Medicine unit within the Atlanta Veterans Affairs Medical Center, and the award is structured as a sole-source arrangement for the specified radiopharmaceuticals. The vendor will be responsible for the full delivery workflow, including handling and transport to support daily operations.
To supply Nuclear Medicine (NM) in the Atlanta Veterans Affairs Healthcare System (ATL VA HCS) with five specific radiopharmaceuticals: Amyvid (F-18 florbetapir); Tauvid (F-18 flortaucipir); Cerianna (F18 fluoroestradiol); Posluma (F18-flotufolastat); Axumin (F-18 fluciclovine). The contract shall be structured as a one-year contract with four (4) optional years. The vendor shall provide all labor, supervision, and transportation necessary to provide daily delivery of Amyvid (F-18 florbetapir); Tauvid (F-18 flortaucipir); Cerianna (F18 fluoroestradiol); Posluma (F18-flotufolastat); Axumin (F-18 fluciclovine) to NM, located in the Atlanta Veterans Affairs Medical Center (ATL VAMC), 1670 Clairmont Road, Decatur, GA 30033.
From Special Notice posted on Jun 10, 2026Notice history
1-
Special Notice LATEST Posted Jun 10, 2026
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA